134 related articles for article (PubMed ID: 17875791)
1. Improved tumor targeting and decreased normal tissue accumulation through extracorporeal affinity adsorption in a two-step pretargeting strategy.
Mårtensson L; Nilsson R; Ohlsson T; Sjögren HO; Strand SE; Tennvall J
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5572s-5576s. PubMed ID: 17875791
[TBL] [Abstract][Full Text] [Related]
2. Reduced myelotoxicity with sustained tumor concentration of radioimmunoconjugates in rats after extracorporeal depletion.
Mårtensson L; Nilsson R; Ohlsson T; Sjögren HO; Strand SE; Tennvall J
J Nucl Med; 2007 Feb; 48(2):269-76. PubMed ID: 17268025
[TBL] [Abstract][Full Text] [Related]
3. Pretargeted radioimmunotherapy with a single-chain antibody/streptavidin construct and radiolabeled DOTA-biotin: strategies for reduction of the renal dose.
Förster GJ; Santos EB; Smith-Jones PM; Zanzonico P; Larson SM
J Nucl Med; 2006 Jan; 47(1):140-9. PubMed ID: 16391198
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunotherapy of A431 xenografted mice with pretargeted B3 antibody-streptavidin and (90)Y-labeled 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-biotin.
Yao Z; Zhang M; Axworthy DB; Wong KJ; Garmestani K; Park L; Park CW; Mallett RW; Theodore LJ; Yau EK; Waldmann TA; Brechbiel MW; Paik CH; Pastan I; Carrasquillo JA
Cancer Res; 2002 Oct; 62(20):5755-60. PubMed ID: 12384535
[TBL] [Abstract][Full Text] [Related]
5. Biotinylation, pharmacokinetics, and extracorporeal adsorption of humanized MAb 111In-MN14 using an avidin-affinity column in rats.
Wang Z; Garkavij M; Ohlsson T; Strand SE; Sjögren HO; Tennvall J
Cancer Biother Radiopharm; 2003 Jun; 18(3):365-75. PubMed ID: 12954123
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein.
Buchsbaum DJ; Khazaeli MB; Axworthy DB; Schultz J; Chaudhuri TR; Zinn KR; Carpenter M; LoBuglio AF
Clin Cancer Res; 2005 Nov; 11(22):8180-5. PubMed ID: 16299250
[TBL] [Abstract][Full Text] [Related]
7. Three-step tumor imaging with biotinylated monoclonal antibody, streptavidin and 111In-DTPA-biotin.
Nakamoto Y; Saga T; Sakahara H; Yao Z; Zhang M; Sato N; Zhao S; Nakada H; Yamashina I; Konishi J
Nucl Med Biol; 1998 Feb; 25(2):95-9. PubMed ID: 9468022
[TBL] [Abstract][Full Text] [Related]
8. Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.
Su FM; Beaumier P; Axworthy D; Atcher R; Fritzberg A
Nucl Med Biol; 2005 Oct; 32(7):741-7. PubMed ID: 16243650
[TBL] [Abstract][Full Text] [Related]
9. In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy.
Lewis MR; Wang M; Axworthy DB; Theodore LJ; Mallet RW; Fritzberg AR; Welch MJ; Anderson CJ
J Nucl Med; 2003 Aug; 44(8):1284-92. PubMed ID: 12902420
[TBL] [Abstract][Full Text] [Related]
10. Improved targeting of radiolabeled streptavidin in tumors pretargeted with biotinylated monoclonal antibodies through an avidin chase.
Yao Z; Zhang M; Kobayashi H; Sakahara H; Nakada H; Yamashina I; Konishi J
J Nucl Med; 1995 May; 36(5):837-41. PubMed ID: 7738661
[TBL] [Abstract][Full Text] [Related]
11. Application of extracorporeal immunoadsorption to reduce circulating blood radioactivity after intraperitoneal administration of indium-111-HMFG1-biotin.
Wang Z; Garkavij M; Tennvall JG; Ohlsson T; Strand SE; Sjögren HO
Cancer; 2002 Feb; 94(4 Suppl):1287-92. PubMed ID: 11877758
[TBL] [Abstract][Full Text] [Related]
12. A novel platform for radioimmunotherapy: extracorporeal depletion of biotinylated and 90Y-labeled rituximab in patients with refractory B-cell lymphoma.
Lindén O; Kurkus J; Garkavij M; Cavallin-Ståhl E; Ljungberg M; Nilsson R; Ohlsson T; Sandberg B; Strand SE; Tennvall J
Cancer Biother Radiopharm; 2005 Aug; 20(4):457-66. PubMed ID: 16114994
[TBL] [Abstract][Full Text] [Related]
13. Radiation absorbed dose estimation for 90Y-DOTA-biotin with pretargeted NR-LU-10/streptavidin.
Breitz HB; Fisher DR; Goris ML; Knox S; Ratliff B; Murtha AD; Weiden PL
Cancer Biother Radiopharm; 1999 Oct; 14(5):381-95. PubMed ID: 10850323
[TBL] [Abstract][Full Text] [Related]
14. Improved intratumoral penetration of radiolabeled streptavidin in intraperitoneal tumors pretargeted with biotinylated antibody.
Zhang M; Yao Z; Saga T; Sakahara H; Nakamoto Y; Sato N; Nakada H; Yamashina I; Konishi J
J Nucl Med; 1998 Jan; 39(1):30-3. PubMed ID: 9443734
[TBL] [Abstract][Full Text] [Related]
15. Pretargeting of bacterial endocarditis in rats with streptavidin and 111In-labeled biotin.
Fogarasi M; Pullman J; Winnard P; Hnatowich DJ; Rusckowski M
J Nucl Med; 1999 Mar; 40(3):484-90. PubMed ID: 10086715
[TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization, and biological evaluation of a streptavidin-chimeric t84.66 conjugate for antibody pretargeting.
Jia F; Shelton TD; Lewis MR
Cancer Biother Radiopharm; 2007 Oct; 22(5):654-64. PubMed ID: 17979568
[TBL] [Abstract][Full Text] [Related]
17. Effect of administration route and dose of streptavidin or biotin on the tumor uptake of radioactivity in intraperitoneal tumor with multistep targeting.
Zhang M; Yao Z; Sakahara H; Saga T; Nakamoto Y; Sato N; Zhao S; Nakada H; Yamashina I; Konishi J
Nucl Med Biol; 1998 Feb; 25(2):101-5. PubMed ID: 9468023
[TBL] [Abstract][Full Text] [Related]
18. PET imaging of apoptosis with (64)Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V.
Cauchon N; Langlois R; Rousseau JA; Tessier G; Cadorette J; Lecomte R; Hunting DJ; Pavan RA; Zeisler SK; van Lier JE
Eur J Nucl Med Mol Imaging; 2007 Feb; 34(2):247-58. PubMed ID: 17021816
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal immunoadsorption compared to avidin chase: enhancement of tumor-to-normal tissue ratio for biotinylated rhenium-188-chimeric BR96.
Chen JQ; Strand SE; Tennvall J; Lindgren L; Hindorf C; Sjögren HO
J Nucl Med; 1997 Dec; 38(12):1934-9. PubMed ID: 9430473
[TBL] [Abstract][Full Text] [Related]
20. High-dose radioimmunotherapy combined with extracorporeal depletion in a syngeneic rat tumor model: evaluation of toxicity, therapeutic effect, and tumor model.
Mårtensson L; Nilsson R; Ohlsson T; Sjögren HO; Strand SE; Tennvall J
Cancer; 2010 Feb; 116(4 Suppl):1043-52. PubMed ID: 20127949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
